عربي
English
Quick links
Related sites
Hotline for Health Services for Displaced Lebanese 1787
Hotline for the Patient Admission to Hospitals 01/832700
COVID-19 Vaccine Registration Form covax.moph.gov.lb
MoPH Hotline 1214
Are you a new member? Sign up now
 
Login area | Sign up
Forgot your password? Click here
Let us help you
Read about the latest topics.
Download the new version of the MOPH app 
for the latest updates on Coronavirus
 
Be Responsible
#Raise your voice
Send us any Fraudulent Action or Enquiry so we can ALL contribute to make a Difference

NCR graphs - Incidence rates by year

- All cancer including non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer including non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- All cancer excluding non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- All cancer excluding non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Oesophagus cancer, crude incidence rate, males, 2005-2015
- Oesophagus cancer, crude incidence rate, females, 2005-2015

- Stomach cancer, crude incidence rate, males, 2005-2015
- Stomach cancer, crude incidence rate, females, 2005-2015

- Colo-rectal cancer, crude incidence rate, males, 2005-2015
- Colo-rectal cancer, crude incidence rate, females, 2005-2015

- Liver cancer, crude incidence rate, males, 2005-2015
- Liver cancer, crude incidence rate, females, 2005-2015

- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, males, 2005-2015
- Gallbladder and extrahepatic bilary tract cancer, crude incidence rate, females, 2005-2015

- Pancreas cancer, crude incidence rate, males, 2005-2015
- Pancreas cancer, crude incidence rate, females, 2005-2015

- Larynx cancer, crude incidence rate, males, 2005-2015
- Larynx cancer, crude incidence rate, females, 2005-2015

- Trachea-bronchus-lung cancer, crude incidence rate, males, 2005-2015
- Trachea-bronchus-lung cancer, crude incidence rate, females, 2005-2015

- Bone cancer, crude incidence rate, males, 2005-2015
- Bone cancer, crude incidence rate, females, 2005-2015

- Melanoma, crude incidence rate, males, 2005-2015
- Melanoma, crude incidence rate, females, 2005-2015

- Non-melanoma skin cancer, crude incidence rate, males, 2005-2015
- Non-melanoma skin cancer, crude incidence rate, females, 2005-2015

- Mesothelioma, crude incidence rate, males, 2005-2015
- Mesothelioma, crude incidence rate, females, 2005-2015

- Breast cancer, crude incidence rate, males, 2005-2015
- Breast cancer, crude incidence rate, females, 2005-2015

- Col uteri cancer, crude incidence rate, females, 2005-2015
- Corpus uteri cancer, crude incidence rate, females, 2005-2015
- Ovary cancer, crude incidence rate, females, 2005-2015

- Prostate cancer, crude incidence rate, males, 2005-2015
- Testis cancer, crude incidence rate, males, 2005-2015

- Kidney cancer, crude incidence rate, males, 2005-2015
- Kidney cancer, crude incidence rate, females, 2005-2015

- Bladder cancer, crude incidence rate, males, 2005-2015
- Bladder cancer, crude incidence rate, females, 2005-2015

- Brain and central nervous system cancer, crude incidence rate, males, 2005-2015
- Brain and central nervous system cancer, crude incidence rate, females, 2005-2015

- Thyroid cancer, crude incidence rate, males, 2005-2015
- Thyroid cancer, crude incidence rate, females, 2005-2015

- Hodgkin's lymphoma, crude incidence rate, males, 2005-2015
- Hodgkin's lymphoma, crude incidence rate, females, 2005-2015

- Non-Hodgkin lymphoma, crude incidence rate, males, 2005-2015
- Non-Hodgkin lymphoma, crude incidence rate, females, 2005-2015

- Lymphoma all types, crude incidence rate, males, 2005-2015
- Lymphoma all types, crude incidence rate, females, 2005-2015

- Multiple myeloma, crude incidence rate, males, 2005-2015
- Multiple myeloma, crude incidence rate, females, 2005-2015

- Lymphoid leukemia, crude incidence rate, males, 2005-2015
- Lymphoid leukemia, crude incidence rate, females, 2005-2015

- Myeloid leukemia, crude incidence rate, males, 2005-2015
- Myeloid leukemia, crude incidence rate, females, 2005-2015

- Leukemia all types, crude incidence rate, males, 2005-2015
- Leukemia all types, crude incidence rate, females, 2005-2015

 
    1
    2
    3
    4
    5
    6
    ...
    13
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
All
ATC Name B/G Ingredients Dosage Form Price
N03AG04 SABRIL B Vigabatrin - 500mg 500mg Tablet, film coated 2,988,706 L.L
A10BH01 SAGIFOR G Sitagliptin (HCl monohydrate) - 100mg 100mg Tablet, film coated 1,242,606 L.L
A10BD07 SAGIMET G Metformin HCl - 1000mg, Sitagliptin (HCl monohydrate) - 50mg Tablet, film coated 1,551,690 L.L
A10BD07 SAGIMET G Metformin HCl - 500mg, Sitagliptin (HCl monohydrate) - 50mg Tablet, film coated 1,432,536 L.L
A10BD07 SAGIMET G Metformin HCl - 850mg, Sitagliptin (HCl monohydrate) - 50mg Tablet, film coated 1,463,892 L.L
L01EA01 SAGITTA G Imatinib - 400mg 400mg Capsule, hard 51,723,840 L.L
L01EA01 SAGITTA G Imatinib - 100mg 100mg Capsule, hard 25,170,264 L.L
J01DE01 SALAPIME G Cefepime - 1g 1g Injectable powder for solution 618,168 L.L
R03AC02 SALBUTAMOL SULFATE G Salbutamol (sulfate) - 2mg 2mg Tablet, scored 401,873 L.L
A07EC02 SALCROZINE G Mesalazine - 500mg 500mg Tablet, gastroresistant 2,013,076 L.L
A07EC02 SALCROZINE G Mesalazine - 1g 1g Tablet, gastroresistant 4,073,187 L.L
A07EC02 SALCROZINE G Mesalazine - 500mg 500mg Suppository 576,508 L.L
A07EC02 SALCROZINE G Mesalazine - 1000mg 1000mg Suppository 2,306,034 L.L
A07EC02 SALOFALK B Mesalazine - 500mg 500mg Tablet, enteric coated 2,874,479 L.L
A07EC02 SALOFALK B Mesalazine - 1000mg 1000mg Granules, gastro-resistant, prolonged release 3,874,298 L.L
A07EC02 SALOFALK B Mesalazine - 1g 1g Suppository 3,948,209 L.L
A07EC02 SALOFALK B Mesalazine - 4g/60ml 4g/60ml Enema 3,796,355 L.L
A07EC02 SALOFALK B Mesalazine - 1.5g 1.5g Granules, gastro-resistant, prolonged release 6,150,767 L.L
A07EC02 SALOFALK B Mesalazine - 3g 3g Granules, gastro-resistant, prolonged release 11,256,652 L.L
A07EC02 SALOFALK 500 B Mesalazine - 500mg 500mg Suppository 677,297 L.L
A02BC01 SANAMIDOL G Omeprazole - 20mg 20mg Capsule 456,906 L.L
A04AA02 SANCUSO G Granisetron - 3.1mg/24h 3.1mg/24h Patch 7,590,728 L.L
L04AD01 SANDIMMUN B Ciclosporin - 50mg/ml 250mg/5ml Injectable concentrated solution 6,992,013 L.L
L04AD01 SANDIMMUN NEORAL B Ciclosporin - 100mg/ml 100mg/ml Solution 8,264,592 L.L
L04AD01 SANDIMMUN NEORAL SOFT GELATIN B Ciclosporin - 50mg 50mg Capsule, soft gelatin 4,309,703 L.L
L04AD01 SANDIMMUN NEORAL SOFT GELATIN B Ciclosporin - 25mg 25mg Capsule, soft gelatin 2,385,320 L.L
L04AD01 SANDIMMUN NEORAL SOFT GELATIN B Ciclosporin - 100mg 100mg Capsule, soft gelatin 8,264,592 L.L
H01CB02 SANDOSTATIN B Octreotide - 0.1mg/ml 0.1mg/ml Injectable solution 1,038,790 L.L
H01CB02 SANDOSTATIN LAR B Octreotide (acetate) - 30mg 30mg Injectable powder for suspension+diluent L.L
H01CB02 SANDOSTATIN LAR B Octreotide (acetate) - 20mg 20mg Injectable powder for suspension+diluent 37,210,097 L.L
    1
    2
    3
    4
    5
    6
    ...
    13
Sitemap
© Copyrights reserved to Ministry of Public Health 2025